Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +39.00p +1.49% 2,650.00p 2,654.00p 2,657.00p 2,739.00p 2,614.00p 2,634.00p 877,524 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2,057.3 256.9 119.6 22.2 5,531

Nmc Health Share Discussion Threads

Showing 726 to 748 of 1425 messages
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
25/3/2019
14:47
mfhmfh - They may well do.....but it's meaningless really.
blackfinance
25/3/2019
12:13
Goldman Sachs today reiterates buy rating and 4,240p target price.
mfhmfh
22/3/2019
22:52
There's likely to be a bounce of sorts.The RSI suggests as much albeit that the stock has plummeted today through a support level around £25-30.Jeffries,who appear to the very astute (but only)bear of NMC must now be nearing a position where they could move from a sell to a hold recommendation.The PE might be in the 20s but arguably a growth stock like NMC is better evaluated with a view to the PEG which is reasonably attractive.That said,Jeffries concerns about NMC would appear to relate to cash flow and worries about the trend in margins.These worries will not easily dissipate.I wouldn't sell at these levels but given the lower lows and lower highs of late would not be tempted to average until there's some sort of clarity.Clarity that these numerous brokers recommending 'buy'can actually muster some share purchases as the stock falls to near half their share price targets.
steeplejack
22/3/2019
18:45
Thanks for the posts. Now, how to go about? Today the stock was down by more than 6.5%. Is it advisable to hold on to this stock and try to average out by adding more stock with each fall or better to sell off and limit the loss. Already, my loss has exceeded GBP 600k. Can anyone suggest a viable option? Thanks.
johnferro1
22/3/2019
18:41
Please read “Can’t understand why the martlet is “NOT” giving the benifit to this stock”. Apologies for the typo error in the earlier post.
johnferro1
22/3/2019
16:31
I sold most of my stock in the 30s.Small holding left to realise a capital loss when it suits.I'll let you know,and you can buy them.
steeplejack
22/3/2019
16:26
Sell up then!
blocker2
22/3/2019
16:20
Not encouraging.Forget buying opportunities.This sort of sustained price fall isn’t to be explained by one ‘maverick̵7; broker at Jeffries banging his drum.When it can’t be readily explained,beware.The very fact that the stock can driven down with such ease,makes it best avoided.In addition,a recommendation a year or so back by the Investors Chronicle identifying this company as a prime private client buy,seals the deal. Does this company rise and fall on Middle East peace concerns?If Trump recognises the Golan Heights as being Israeli,is that worth giving the stock a good hammering?
steeplejack
22/3/2019
13:29
the martlet is giving the benifit WOW!
59stevo
22/3/2019
12:08
Seems odd the share price is down over 3% on very little volume considering the volume yday. Worth a long?
waldo2020
22/3/2019
09:42
Big holding...think it's the high PE that's the probelm.
brain smiley
22/3/2019
09:17
Can anyone explain why the share price is falling despite a very good result at the challenging environment. The group has reiterated its positive guidance for the coming year also. The management team sound very confident with the growth prospects. All the analysts except Jeffries have got a buy recommendation with TP of Gbp 4000 plus. Can’t understand why the martlet is giving the benifit to this stock. Stuck with more than 50k shares with an average price of Gbp 3700.
johnferro1
11/3/2019
15:12
Barclays Capital reiterate OVERWEIGHT and 4500p target
aishah
08/3/2019
12:55
Tssmith..a special aura surrounding anything to do with health and currently seen at a premium..this one racing back up to a p/e of 25 even now. The future I guess. You'd think the same about renewables..nope Greencoat Wind on a p/e of just 7 off its recently announced annuals( admittedly with a bit of balance sheet messing on turbine amortisation). Health shares very much in fashion in spite of recent falls.
stewart64
08/3/2019
12:21
Support around £20. would look to see for it to hit and bounce off support before taking position. good solid company, valuation just too high
tsmith2
08/3/2019
11:17
Shares with a price to earnings of 24 have high growth expectation at such a rich valuation ( higher still yesterday)...20% growth didn't cut it or EPS of 101.5p. EPS $1.40 expected, $1.33 result.
stewart64
08/3/2019
09:48
Buying opportunities
blocker2
08/3/2019
09:43
This is fairly appalling for the simple reason that neither press or broker can satisfactorily explain why these shares are plummeting post the results.Oh you can read Jeffries but albeit the price has fallen,they’re examining the exact same data as Goldmans and others.There is the question about receivables,a concern that appears to be borne out in the rising finance charge but this price slump appears to go further than that.It seems to suggest there’s something almost untoward in the accounting.That the whole corporate strategy is wayward.The company has been bundled into a category reserved for the likes of Micro Focus.Its got a nasty feel of real manipulation which luckily pushed me to sell out of one portfolio back in the mid 30s but I still have a smallish holding elsewhere.
steeplejack
07/3/2019
18:33
Broker Comment"The market ran out of steam and the traders are now more in agreement about the bearishness. The evidence is strong enough to prompt the closing of long positions." But then it may be time to take a contrarian view, health problems are not going to go away.
jackdaw4243
07/3/2019
17:21
Goldman’s thinks that some of the concerns identified by the market (primarily Jeffries I suppose) have been addressed in these final results.That’s not to ignore the fact that Jeffries have got this right .The shares are down from over forty quid in a little over six months.This is despite Berenberg having a target price of £54 and going on record back in November as saying the shares could be a hundred pounds 4 years hence.Barclays has it as its “pick” buy and the less said about the Investors Chronicle optimism the better.The forecast multiple is now mid 20s and despite the absence of any yield to speak of,the stock looks pretty well oversold.Its over a third down since the autumn and frankly,even the bears might be reluctant to squeeze another 10% downside out of this one to hit the £23 Jeffries TP (presuming they haven’t cut it further!). https://www.sharecast.com/news/news-and-announcements/nmc-health-hails-another-year-of-record-profits-and-earnings--3780016.html
steeplejack
07/3/2019
16:31
Anybody know where I can find broker forecasts on the back of today's results?
hiraniha
07/3/2019
15:42
They didn't beat expectations. It's a bloody tough market at the moment.
johnrxx99
07/3/2019
15:40
smartinvest what changed you mind to up you target from 20?
mdr26nlz
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older
Your Recent History
LSE
NMC
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 23:31:43